查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825357

二氧化碳测量仪市场 - 预测 2025-2030

Capnography Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

二氧化碳测量仪市场预计将从 2025 年的 18.91 亿美元成长到 2030 年的 29.77 亿美元，复合年增长率为 9.50%。

二氧化碳测量仪市场趋势

二氧化碳测量仪用于测量患者呼出气体中二氧化碳的浓度或分压。它是重症加护室、恢復室、病房和救护车等环境中必不可少的监测设备。作为一种非侵入性方法，它可以快速识别人工呼吸器故障、气管插管位置不当和呼吸管路缺陷等呼吸问题。此技术以波形显示呼出的二氧化碳，指示整个呼吸週期中的二氧化碳含量。

技术进步是二氧化碳测量仪市场的主要驱动力，使疾病检测能够更早、更有效率地进行。然而，由于脉搏血氧计等替代技术（该技术也可监测呼吸）的存在，以及二氧化碳测量仪在测量非插管患者呼吸频率方面的不可靠性，市场成长面临限制。

呼吸系统疾病（包括感染疾病、气喘、肺癌和慢性阻塞性肺病(COPD)）的盛行率在已开发国家和新兴国家均呈现上升趋势，持续推动市场扩张。这些慢性疾病会长期影响呼吸道和肺部结构，使呼吸道症状成为初级保健就诊的主要原因。吸烟仍然是导致盛行率上升的主要原因，而与吸烟相关的 COPD 在全球范围内影响大量人口。

日间手术中心 (ASC) 提供的服务种类和数量正在急剧扩张，涵盖了包括心臟病学在内的多个专科。即使是传统的医院内置换术，也正在转向 ASC。这项转变凸显了门诊病人在医疗保健服务中日益重要的角色。

技术创新的不断推进、呼吸系统疾病盛行率的上升以及政府推广先进监测技术的倡议，进一步推动了市场的成长。二氧化碳测量仪在病患监测中的应用日益广泛，这得益于其在管理呼吸系统疾病方面的卓越可靠性和效率，从而改善了整体医疗保健效果。

二氧化碳测量仪市场細項分析

预计预测期内，二氧化碳测量仪在心臟护理中的应用将持续扩大，推动市场成长。这一快速增长的驱动力源于全球心血管疾病 (CVD) 盛行率的上升以及手术数量的增加。心血管疾病（例如 CVD、先天性心臟疾病(CHD) 和中风）是全球主要死因之一。据预测，到 2030 年，CVD 可能导致全球约 2,360 万人死亡。值得注意的是，约 80% 的 CVD 相关死亡发生在非洲、拉丁美洲和亚太等中低收入地区。

加剧心血管疾病（CVD）发展的主要风险因素包括过量饮酒和吸烟、不良饮食习惯以及久坐不动的生活方式。这些因素导致心臟病发病率上升，并增加了循环系统科对二氧化碳测量仪设备的需求。这种情况可能导致死亡人数迅速增加，从而需要强大的监测工具，并进一步增加需求。

一个显着的趋势是，ASC 正转向照护现场心臟护理服务，这进一步支持了二氧化碳测量仪的应用。随着病患照护日益转向门诊病人，ASC 正逐渐成为传统医院经济高效、高品质的替代方案。这一发展趋势支持更广泛的手术，包括心臟介入治疗，二氧化碳测量仪可确保在手术和恢復期间进行即时呼吸监测。

总体而言，二氧化碳测量仪市场预计将持续成长，因其在应对呼吸和心臟挑战方面发挥关键作用。儘管存在技术竞争，但其非侵入性特性和基于波形的竞争考察在关键临床场景中具有显着优势。行业相关人员应密切关注与其他监测系统的整合进展以及监管支持，以抓住门诊和重症患者监护领域的新兴机会。强调插管患者的可靠性，并努力提高非插管病例的准确性，将是克服市场限制、扩大市场渗透率的关键。

本报告的主要优点

  • 深刻分析：获得深入的市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，既有利又划算。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 分析范围
  • 细分市场

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章二氧化碳测量仪市场（依产品类型）

  • 介绍
  • 侧流二氧化碳测量仪
  • 主流二氧化碳测量仪
  • 微流二氧化碳二氧化碳测量仪

第六章二氧化碳测量仪市场（依应用）

  • 介绍
  • 程序镇静
  • 疼痛管理
  • 紧急医疗
  • 麻醉监测
  • 加护治疗
  • 其他的

第七章二氧化碳测量仪市场（依最终用户划分）

  • 介绍
  • 医院
  • 门诊手术中心（ASC）
  • 紧急医疗服务（EMS）
  • 居家医疗
  • 诊断实验室

第八章二氧化碳测量仪市场（按地区）

  • 介绍
  • 北美洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章：竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪表板

第十章：公司简介

  • Medtronic plc
  • Masimo Corporation
  • Dragerwerk AG & Co. KGaA
  • Koninklijke Philips NV
  • ICU Medical
  • Nonin Medical Inc.
  • Nihon Kohden Corporation
  • Becton, Dickinson and Company（BD）
  • Zoll Medical Corporation

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061610464

The Capnography Market is expected to grow from USD 1.891 billion in 2025 to USD 2.977 billion in 2030, at a CAGR of 9.50%.

Capnography Market Trends

Capnography involves measuring the concentration or partial pressure of carbon dioxide in patients' exhaled breath. It serves as essential monitoring equipment in settings such as critical care, recovery rooms, wards, and ambulances. As a non-invasive method, it enables rapid identification of respiratory issues, including ventilator failure, tracheal tube malposition, and defective breathing circuits. The technology presents exhaled CO2 as a waveform, illustrating CO2 levels throughout the respiratory cycle.

Technological advancements are a primary driver of the capnography market, enabling earlier and more efficient disease detection. However, market growth faces limitations from alternative technologies like pulse oximetry, which also monitors respiration, and the unreliability of capnography for measuring respiratory rates in non-intubated patients.

The escalating prevalence of respiratory diseases-including infections, asthma, lung cancer, and chronic obstructive pulmonary disease (COPD)-in both developed and developing countries continues to propel market expansion. These chronic conditions affect airways and lung structures over extended periods, making respiratory symptoms a leading reason for primary care consultations. Smoking remains a key contributor to this rise, with COPD linked to tobacco use impacting significant populations worldwide.

Ambulatory surgical centers (ASCs) have seen substantial expansion in service types and volumes, encompassing diverse specialties like cardiology. Even fields traditionally hospital-based, such as spine and joint replacements, are increasingly shifting to ASCs. This transition underscores the growing role of outpatient settings in healthcare delivery.

Market growth is further supported by ongoing technological innovations, the rising incidence of respiratory diseases, and government initiatives promoting advanced monitoring. The increasing adoption of capnography for patient monitoring stems from its superior reliability and efficiency in managing respiratory conditions, enhancing overall medical outcomes.

Capnography Market Segmentation Analysis

The expanding applications of capnography in cardiac care are poised to drive market growth during the forecast period. This surge is fueled by the increasing prevalence of cardiovascular diseases (CVDs) and a growing volume of global surgeries. Heart conditions, including CVD, congenital heart disease (CHD), and stroke, rank among the top causes of mortality worldwide. Projections indicate that by 2030, CVDs could account for approximately 23.6 million deaths globally. Notably, around 80% of CVD-related deaths occur in low- and middle-income regions, such as Africa, Latin America, and Asia-Pacific.

Key risk factors exacerbating CVD incidence include excessive alcohol and tobacco consumption, poor dietary habits, and sedentary lifestyles. These elements contribute to rising heart disease rates, which in turn heighten the need for capnography devices in cardiology. The demand is amplified by the potential for rapid fatalities from these conditions, necessitating robust monitoring tools.

A notable trend is the shift toward point-of-care cardiac services in ASCs, which further boosts capnography adoption. As patient care increasingly moves to outpatient environments, ASCs emerge as cost-effective, high-quality alternatives to traditional hospitals. This evolution supports broader procedural scopes, including cardiac interventions, where capnography ensures real-time respiratory oversight during surgeries and recovery.

Overall, the capnography market is positioned for sustained growth, driven by its critical role in addressing respiratory and cardiac challenges. While technological alternatives pose competition, the device's non-invasive nature and waveform-based insights provide distinct advantages in high-stakes clinical scenarios. Industry stakeholders should monitor advancements in integration with other monitoring systems and regulatory support to capitalize on emerging opportunities in ambulatory and critical care settings. The focus on reliability for intubated patients, combined with efforts to improve accuracy for non-intubated cases, will be key to overcoming restraints and expanding market penetration.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Capnography Market Segmentation:

By Product Type

  • Sidestream Capnographs
  • Mainstream Capnographs
  • Microstream Capnographs

By Application

  • Procedural Sedation
  • Pain Management
  • Emergency Medicine
  • Anesthesia Monitoring
  • Critical Care
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Emergency Medical Services (EMS)
  • Homecare Settings
  • Diagnostic Laboratories

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CAPNOGRAPHY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Sidestream Capnographs
  • 5.3. Mainstream Capnographs
  • 5.4. Microstream Capnographs

6. CAPNOGRAPHY MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Procedural Sedation
  • 6.3. Pain Management
  • 6.4. Emergency Medicine
  • 6.5. Anesthesia Monitoring
  • 6.6. Critical Care
  • 6.7. Others

7. CAPNOGRAPHY MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers (ASCs)
  • 7.4. Emergency Medical Services (EMS)
  • 7.5. Homecare Settings
  • 7.6. Diagnostic Laboratories

8. CAPNOGRAPHY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Medtronic plc
  • 10.2. Masimo Corporation
  • 10.3. Dragerwerk AG & Co. KGaA
  • 10.4. Koninklijke Philips N.V.
  • 10.5. ICU Medical
  • 10.6. Nonin Medical Inc.
  • 10.7. Nihon Kohden Corporation
  • 10.8. Becton, Dickinson and Company (BD)
  • 10.9. Zoll Medical Corporation

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations